The protective role of Lychnophora ericoides Mart. (Brazilian Arnica) in 1,2-dimethylhydrazine-induced experimental colon carcinogenesis

Nutrition and Cancer

Volumn 63, Issue 4, 2011, Pages 593-599

  Fernandes, Cleverson Rodrigues ^a   Turatti, Aline ^a   Gouvea, Dayana Rubio ^a   Gobbo Neto, Leonardo ^a   Diniz, Andrea ^a   Ribeiro Silva, Alfredo ^a   Lopes, Norberto Peporine ^a   Garcia, Sérgio Britto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; LYCHNOPHORA ERICOIDES EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ABERRANT CRYPT FOCUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL NEOPLASM; MALE; NONHUMAN; RAT;

1,2-DIMETHYLHYDRAZINE; ABERRANT CRYPT FOCI; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ARNICA; CARCINOGENS; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; INTESTINAL MUCOSA; MALE; NEOPLASMS, EXPERIMENTAL; PHYTOTHERAPY; PLANT EXTRACTS; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR;

ARNICA; LYCHNOPHORA ERICOIDES; RATTUS; RATTUS NORVEGICUS;

EID: 79957609293     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.539310     Document Type: Article

References (40)

1. Hanausek M, Walaszek Z, and Slaga TJ: Detoxifying cancer causing agents to prevent cancer. Integr Cancer Ther 2, 139-144, 2003. (Pubitemid 37322458)
2. Robinson H: Notes on Lychnophorinae from Minas Gerais, Brazil, a synopsis of Lychnophoriopsis Schultz, and the new genera Anteremanthus and Minasia (Vernonieae, Asteraceae). Proc Biol Soc Wash 105, 640-652, 1992.
3. Gobbo-Neto L, Santos MD, Kanashiro A, Almeida MC, Lucisano-Valim YM, et al.: Evaluation of the antiinflammatory and antioxidant activities of di-C-glucoflavones from Lychnophora ericoides (Asteraceae). Planta Med 71, 3-6, 2005. (Pubitemid 40223344)
4. Vasconcellos MC, Rosa RM, Machado MS, Villela IV, Crotti AE, et al.: Genotoxicity of 15-deoxygoyazensolide in bacteria and yeast. Mutat Res 631, 16-25, 2007. (Pubitemid 46823916)
5. Sakamoto HT, Flausino D, Castellano EEC, Stark CBW, Gates PJ, et al.: Sesquiterpene lactones from Lychnophora ericoides. J Nat Prod 66, 693-695, 2003. (Pubitemid 36617899)
6. dos Santos MD, Gobbo-Neto L, Albarella L, de Souza GE, and Lopes NP: Analgesic activity of di-caffeoylquinic acids from roots of Lychnophora ericoides (Arnica da serra). J Ethnopharmacol 96, 545-549, 2005.
7. dos Santos MD, Almeida MC, Lopes NP, and de Souza GE: Evaluation of the antiinflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm Bull 29, 2236-2240, 2006.
8. Limasset B, Ojasoo T, Le Doucen C, and Doré JC: Inhibition of chemiluminescence in human PMNs by monocyclic phenolic acids and flavonoids. Planta Med 65, 23-29, 1999. (Pubitemid 29077423)
9. dos Santos MD, Chen G, Almeida MC, Soares DM, de Souza GEP, et al.: Effects of caffeoylquimic acid derivatives and c-flavonoid from lychnophora ericoides on in vitro inflammatory mediator production. Nat Prod Comm 5, 733-740, 2010.
10. dos Santos PA, Amarante MF, Pereira AM, Bertoni B, França SC, et al.: Production of an antiproliferative furanoheliangolide by Lychnophora ericoides cell culture. Chem Pharm Bull (Tokyo) 52, 1433-1435, 2004
11. Gobbo-Neto L, Guaratini T, Pessoa C, de Moraes MO, Costa-Lotufo LV, et al.: Differential metabolic and biological profiles of Lychnophora ericoides Mart. (Asteraceae) from different localities in the Brazilian "campos rupestres." J Braz Chem Society 21, 750-759, 2010.
12. Pozharisski KM, Likhachev AJ, Klimashevski VJ, and Shaposhnikov JD: Experimental intestinal cancer research with special reference to human pathology. Adv Cancer Res 30, 165, 1979.
13. Pozharisski KM: Tumours of the intestines. In: Pathology of Tumours in Laboratory Animals: Vol. 1. Tumours of the Rat, 2nd ed., Turusov VS and Mohr U (eds.). Lyon, France: IARC Sci. Publ. No. 99, 1990, 159-198.
14. Bird RP: Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37, 147-151, 1987.
15. McLellan KR and Bird RP: Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 48, 6187-6192, 1988.
16. Bird RP: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93, 55-71, 1995.
17. Fenoglio-Preiser CM and Noffsinger A: Aberrant crypt foci: a review. Toxicol Pathol 27, 632-642, 1999.
18. Hikita H, Vaughan J, Babcock K, and Pitot HC: Short-term fasting and the reversal of the stage of promotion in rat hepatocarcinogenesis: role of cell replication, apoptosis, and gene expression. Toxicol Sci 52(Suppl), 17-23, 1999. (Pubitemid 30017571)
19. Tanaka T, Kawabata KM, Kakumoto H, Makita H, and Hara A: Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats. Carcinogenesis 18, 2155-2161, 1997. (Pubitemid 28134743)
20. Barsoum GH, Hendrickse C, Winslet MC, Young D, and Donovan IA: Reduction of mucosal crypt cell proliferation in patients with colorectal adenomatous polyps by dietary calcium supplementation. Br J Surg 79, 581-583, 1992.
21. Mori H, Sugie S, Yoshimi N, Hara A, and Tanaka T: Control of cell proliferation in cancer prevention. Mutat Res 428, 291-298, 1999. (Pubitemid 29389700)
22. Baron JA and Sandler RS: Nonsteroidal antiinflammatory drugs and cancer prevention. Annu Rev Med 51, 511-523, 2000. (Pubitemid 30216052)
23. Oshima M, Dinchuk JE, and Kargman SL: Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (Cox-2). Cell 87, 803-809, 1996. (Pubitemid 26404280)
24. Rodrigues MA, Silva LA, Salvadori DM, De Camargo JL, and Montenegro MR: Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med Biol Res 35, 351-355, 2002. (Pubitemid 34285508)
25. Gobbo-Neto L and Lopes NP: Online identification of chlorogenic acids, sesquiterpene lactones and flavonoids in the Brazilian arnica Lychnophora ericoides Mart. (Asteraceae) leaves by HPLC-DAD-MS and -MS/MS and a validated HPLC-DAD method for their simultaneous analysis. Agri Food Chem 56, 1193-1204, 2008.
26. Shpitz B, Bomstein Y, Mekori Y, Cohen R, Kaufman Z, et al.: Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon. Am J Surg 174, 425-430, 1997. (Pubitemid 27444174)
27. Garcia SB, Turatti A, Ribeiro-Silva A, and Zucoloto S: Sequential analyses of the growth of activated foci with increased expression of CD34, CD68, a smooth muscle actin, and COX-2 in the rat colon carcinogenesis: putative markers of field cancerization and relationship with increased crypt fission rates. Mod Pathol 20, 114, 2007.
28. Demarzo MM, Martins LV, Fernandes CR, Herrero FA, Perez SE, et al.: Exercise reduces inflammation and cell proliferation in rat colon carcinogenesis. Med Sci Sports Exerc 40, 618-621, 2008. (Pubitemid 351416864)
29. Groombridge B and Jenkins MD: World Atlas of Biodiversity. University of California Press, Berkeley, CA, 2002.
30. Raju J: Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer. World J Gastroenterol 14, 6632-6635, 2008.
31. Rogers CJ, Colbert LH, Greiner JW, Perkins SN, and Hursting SD: Physical activity and cancer prevention: pathways and targets for intervention. Sports Med 38, 271-296, 2008. (Pubitemid 351430296)
32. Wattenberg LW: Chemoprevention of cancer. Cancer Res 45, 1-8, 1985.
33. Wendum D, Maliah J, Trugnan G, and Flejou FJ: Cyclooxigenase-2 and its role in colorectal cancer development. Virchows Arch 445, 327-333, 2004. (Pubitemid 39517756)
34. Tomazawa S, Tsuno NH, Hatano K, Osada T, Kitayama J, et al.: Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer 81, 1274-1279, 1999.
35. Latifah SY, Armania N, Tze TH, Azhar Y, Nordiana AH, et al.: Germinated brown rice (GBR) reduces the incidence of aberrant crypt foci with the involvement of beta-catenin and COX-2 in azoxymethane-induced colon cancer in rats. Nutr J 26, 9-16, 2010.
36. Loukanov T, Kirilov M, Fürstenberger G, and Müller-Decker K: Localization of cyclo-oxygenase-2 in human recurrent colorectal cancer. Clin Invest Med 33, 22-29, 2010.
37. Terzić J, Grivennikov S, Karin E, and Karin M: Inflammation and colon cancer. Gastroenterology 138, 2101-2114, 2010.
38. Chan AT, Ogino S, and Fuchs CS: Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302, 649-658, 2009.
39. Shahidi F and Chandrasekara A: Hydroxycinnamates and their in vitro and in vivo antioxidant activities. Phytochem Rev 9, 147-170, 2010.
40. Dobrovolskaia MA and Kozlov SV: Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership. Curr Cancer Drug Targets 5, 325-344, 2005. (Pubitemid 41097757)